{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:36:54Z","timestamp":1786700214903,"version":"build-2736575974"},"reference-count":250,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Prostate cancer is formed of a heterogeneous population of cancer cells with different biological properties. They initially form a small part of the normal stromal microenvironment but are able, through cell-to-cell contact and via exosomes, small nanoparticles containing DNA, mRNA, microRNA, long non-coding RNA, enzymes, and chemokines and cytokines, to transform the normal stromal cells into tumour-associated cells to create an immunosuppressive environment as well as inhibit the antitumour immune response. Matrix metalloproteinases are able to degrade not only the basement membrane but also the extracellular matrix, allowing the exosomes to disseminate via the circulation. Exosomes are organotrophic, homing in to specific tissues such as bone. Here, they create the premetastatic niche devoid of cancer cells and cause an immunosuppressive environment, as well as induce changes in the host cells and produce myeloid-derived suppressor cells, of which some migrate to the primary tumour inhibiting the antitumour immune response further. Prostate cancer cells can disseminate even before the cancer is detected and thus escape curative therapy. If they survive the shear forces of the circulation and the antitumour immune response, they are able to implant in the premetastatic niche, transforming it into the metastatic niche. Here, they enter a latent state or dormancy period, which may last for months or years but later can \u201cawake\u201d to form metastasis. This review critically analyses the cellular and molecular mechanisms, which produce this process from cellular aspects to the signalling pathways responsible for this process. Multiple mechanisms are involved in a coordinated fashion to permit the survival of the cancer cells, from cellular changes in host cells and immunomodulation via chemokines and cytokines. It emphasizes the role of microRNAs and long non-coding RNAs in this process, and that patients with higher Gleason scores have a worse prognosis in terms of biochemical free survival at 10 years. Therefore, a precision medical approach may improve the biochemical free survival rate without affecting the role of the signalling pathways in normal cells. This includes the modulation of interleukin expression, elimination of exosomes, or the inhibition of important enzymes, such as MMP-2, thus mitigating the residual recurrence risk that persists with conventional therapy.<\/jats:p>","DOI":"10.3390\/ijms27167256","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:04:01Z","timestamp":1786698241000},"page":"7256","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-8550","authenticated-orcid":false,"given":"Nigel P.","family":"Murray","sequence":"first","affiliation":[{"name":"Hospital de Carabineros de Chile, Santiago 7630568, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"2018 Cancer Statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA J. Cancer Clin."},{"key":"ref_2","first-page":"485","article-title":"Prostate cancer statistics","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"6110","article-title":"Detection of hematogenous micrometastasis in patients with prostate cancer","volume":"52","author":"Moreno","year":"1992","journal-title":"Cancer"},{"key":"ref_4","first-page":"953","article-title":"Rendimiento diagnostico de la c\u00e9lulas prost\u00e1ticas malignas en la circulacion sangu\u00ednea para la deteccion precoz de cancer prostatico: Una comparaci\u00f3n con la biopsia prostatica","volume":"64","author":"Murray","year":"2011","journal-title":"Arch. Esp. Urol."},{"key":"ref_5","first-page":"5355","article-title":"Histological subtypes of prostate cancer: A comparative survival study","volume":"17","author":"Kendal","year":"2010","journal-title":"Can. J. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41391-024-00866-4","article-title":"Rare histological prostate cancer subtypes: Cancer specific and other cause mortality","volume":"28","author":"Siech","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_7","first-page":"241","article-title":"Gland and cell-level heterogeneity in the prostate: A narrative review of related diseases","volume":"19","author":"Wang","year":"2025","journal-title":"Curr. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Elbe","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Niland, S., and Elbe, J.A. (2020). Hold on or cut? Integrin and MMP mediated cell-matrix interactions in the tumor microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010238"},{"key":"ref_10","first-page":"1881","article-title":"Proliferating fibroblasts and HeLa cells co-cultured in vitro influence growth patterns, protein expression, chromatin features and cell survival","volume":"35","author":"Delinasios","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000533773","article-title":"Co-culture device for in vitro high throughput analysis of cancer associated fibroblast and cancer cell interactions","volume":"102","author":"Germain","year":"2024","journal-title":"Oncology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17188","DOI":"10.1073\/pnas.1419554111","article-title":"Inhibition of tumor cell proliferation and motility of fibroblasts is both contact and soluble factor dependent","volume":"111","author":"Alkasalis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41598-021-03134-w","article-title":"Fibroblast mediated uncaging of cancer cells and dynamic evolution of the physical microenvironment","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","article-title":"The multifaceted role of the stroma in the healthy prostate and prostate cancer","volume":"22","author":"Sorrentino","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pros.23985","article-title":"Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins","volume":"80","author":"Ojalill","year":"2020","journal-title":"Prostate"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/19336918.2016.1182292","article-title":"Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways","volume":"1","author":"Suhovskih","year":"2017","journal-title":"Cell Adh. Migr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bai, S., Wang, Z., Wang, M., Li, J., Wei, Y., Xu, R., and Du, J. (2022). Tumor derived exosomes modulate primary site tumor metastasis. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.752818"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Akoto, T., and Saini, S. (2021). Role of exosomes in prostate cancer metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073528"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","article-title":"ExoCarta: A Web-based compendium of exosomal cargo","volume":"428","author":"Keerthikumar","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1083\/jcb.201704053","article-title":"Cancer associated fibroblasts promote cancer cell migration by aligning fibronectin","volume":"216","author":"Ergodan","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1039\/D4SM00335G","article-title":"Tensile force field plays a crucial role in local invasion of tumor cells through a mechano-chemical coupling mechanism","volume":"20","author":"Meng","year":"2024","journal-title":"Soft Matter"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e22440","DOI":"10.1002\/advs.202522440","article-title":"Single-cell morphomechanics of prostate cancer-associated fibroblasts identifies distinct features associated with prostate cancer","volume":"13","author":"Garside","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pan, J., Ma, Z., Liu, B., Qian, H., Shoa, X., Liu, J., Wang, Q., and Wue, W. (2023). Identification of cancer associated fibroblasts subtypes in prostate cancer. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1133160"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"188901","DOI":"10.1016\/j.bbcan.2023.188901","article-title":"Epigenetic relation of cancer-associated fibroblast heterogenenity","volume":"1878","author":"Kehrberg","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T-cell activation and limit responsivenss to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1038\/s41467-024-53233-1","article-title":"Iron loaded cancer-associated fibroblasts induce immunosuppression in cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1186\/s12885-024-13006-x","article-title":"Comparative transcriptome of normal and cancer associated fibroblasts","volume":"24","author":"Abikar","year":"2024","journal-title":"BMB Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13046-020-1542-z","article-title":"YAP1 plays a key role of the conversion of normal fibroblasts into cancer associated fibroblasts that contribute to prostate cancer progression","volume":"39","author":"Shen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1111\/febs.15816","article-title":"SOX9 in prostate cancer is up rgulated by cancer associated fibroblasts to promote tumor progression through HGF\/c-MET-FRA1 signalling","volume":"288","author":"Qin","year":"2021","journal-title":"FEBS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41419-026-08512-8","article-title":"The research advances in crosstalk between cancer Associated fibroblasts and tumour cells using co-culture organoids","volume":"17","author":"Wang","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/s41598-019-39553-z","article-title":"Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs","volume":"9","author":"Yavuz","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"Cell exclusion, immune privilege and tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10555-013-9479-8","article-title":"Immunotherapy for prostate cancer: Recent developments and future challenges","volume":"33","author":"Schweizer","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.5VMR1116-491RR","article-title":"Myeloid-derived cells in prostate cancer progression, phenotype and prospective therapies","volume":"102","author":"Drake","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ positive T cell states in human cancer: Insights from single-cell analysis","volume":"20","author":"Thommen","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-016-0381-z","article-title":"Is CD47 an innate immune checkpoint for tumor evasion?","volume":"10","author":"Liu","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12967-025-06519-x","article-title":"Macrophages in prostate cancer: Dual roles in tumor progression and immune evasion","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.1074\/jbc.M114.571620","article-title":"Polarization of prostate associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8) mediated efferocytosis","volume":"289","author":"Soki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pros.23155","article-title":"Prostate cancer derived Cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages","volume":"76","author":"Cha","year":"2016","journal-title":"Prostate"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e143729","DOI":"10.1172\/JCI143729","article-title":"Hypoxia inducible factor promotes antitumour effector function and tissue residency by CD8+ T cells","volume":"131","author":"Liikanen","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Malfitano, A.M., Psanti, F., Napolitano, F., Di Somma, S., Martinelli, R., and Portella, R. (2020). Tumor associated macrophage status in cancer treatment. Cancers, 12.","DOI":"10.3390\/cancers12071987"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s11307-019-01318-5","article-title":"Imaging and characterization of macrophage distribution in mouse models of human prostate cancer","volume":"21","author":"Copeland","year":"2019","journal-title":"Mol. Imaging Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Vito, A., El-Sayes, N., and Mossman, K. (2020). Hypoxia-driven immune escape in the tumor microenvironment. Cells, 9.","DOI":"10.3390\/cells9040992"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/s41467-025-61560-0","article-title":"YY1 enhances HIF-1\u03b1 stability in tumour associated macrophages to suppress antitumor immunity of prostate cancer in mice","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1002\/jcp.29784","article-title":"Tumor associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer","volume":"235","author":"Guan","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Guan, H., Mao, L., Wang, J., Wang, S., Yang, S., Wu, H., Sun, W., Chen, Z., and Chen, M. (2022). Exosomal RNF157 mRNA from prostate cancer cells contribute to M2 macrophage polarization through destabilizing HDAC1. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1021270"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Costanzi, E., Romani, R., Scarpelli, P., and Bellezza, I. (2020). Extracellular vesicule mediated transfer of miRNA Let-7b from PC3 cells To Macrophages. Genes, 11.","DOI":"10.3390\/genes11121495"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"26138","DOI":"10.1038\/s41598-025-11799-w","article-title":"Prostate cancer-cell derived exosomes inhibit macrophage phagocytosis through EIF3B mediated exosomal sorting of miR-100-5p","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy","volume":"81","author":"Yang","year":"2021","journal-title":"Prostate"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euf.2017.05.013","article-title":"PD- L1 expression and CD8+ T-cell infiltrate are associated with node-positive prostate cancer","volume":"5","author":"Petitprez","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3 (+) subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ejca.2012.11.035","article-title":"High tissue density of FOXP3 T cells is associated with clinical outcome in prostate cancer","volume":"49","author":"Flammiger","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/pros.23890","article-title":"Increased infiltration of CCR4 positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis","volume":"79","author":"Watanabe","year":"2019","journal-title":"Prostate"},{"key":"ref_57","first-page":"9","article-title":"B cell and B cell related pathways for novel cancer treatments","volume":"73","author":"Tokunga","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Catalan, D., Mansilla, M.A., Ferrier, A., Soto, L., Oleinika, K., Aguillon, J.C., and Aravena, O. (2021). Immunosuppressive mechanisms of regulatory B cells. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.611795"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12939","article-title":"Regulatory B cells in cancer","volume":"299","author":"Michaud","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166685","DOI":"10.1016\/j.jmb.2020.10.019","article-title":"Regulatory B cells in cancer","volume":"433","author":"Horli","year":"2021","journal-title":"J. Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"107581","DOI":"10.1016\/j.intimp.2021.107581","article-title":"Role of regulatory B cells in gastric cancer: Latest evidence and therapeutic Strategies","volume":"96","author":"Jing","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cei\/uxac029","article-title":"Mechanisms of induction of regulatory B cells in the tumour microenvironment and pro-tumour Response","volume":"209","author":"Blair","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"13083","DOI":"10.1038\/s41598-019-49581-4","article-title":"Increased regulatory B cells are involved in immune evasion in patients with gastric cancer","volume":"9","author":"Murakami","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21 induced granzyme-B expressing B cells infiltrate tumors and regulate T cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Saudi, A., Banday, V., Zirakzadeh, A.A., Selinger, M., Forsberg, J., Holmbom, M.E.T., Henriksson, J., Walden, M., Alamdar, F., and Aljabery, F. (2023). Immune activated B cells are dominant in PCa. Cancers, 15.","DOI":"10.3390\/cancers15030920"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4314\/ahs.v20i3.31","article-title":"Frequency of IL- 10+CD19+B cells in patients to patients with benign prostate hyperplasia","volume":"3","author":"Roya","year":"2020","journal-title":"Afr. Health Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Tian, W., Li, Y., Li, J., Liang, C., Cai, S., Wen, B., Tan, Z., Wu, Z., Deng, Y., and Liu, Z. (2026). Regulatory B cells and SIVA1-LAG3 immune suppression predict poor survival in prostate cancer. Biomol. Biomed., online ahead of print.","DOI":"10.17305\/bb.2026.14056"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive tumor environment via integrated single-cell and spatial transcriptomic analysis","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yang, Y., Chen, X., Pan, J., Ning, H., Zhang, Y., Bo, Y., Ren, X., Li, J., Qin, S., and Wang, D. (2024). Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes. Cells, 187.","DOI":"10.1016\/j.cell.2024.06.038"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/ncomms2533","article-title":"Siva1 inhibits p53b function by acting as an ARF E3 ubiqutin ligase","volume":"4","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1038\/sj.onc.1209381","article-title":"Siva1 negatively regulates NF- kappaB activity: Effect on T-cell receptor mediated activation-induced cell death","volume":"25","author":"Gudi","year":"2006","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"12851","DOI":"10.1073\/pnas.1017372108","article-title":"Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Dudek, A.M., Martin, S., Garg, A.D., and Agostinis, P. (2013). Immature, semi-immature and fully mature dendritic cells: Toward a DC- cancer cells interface that augments an anticancer immunity. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00438"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"105374","DOI":"10.1016\/j.phrs.2020.105374","article-title":"Dendritic cell vaccine therapy for colorectal cancer","volume":"164","author":"Wooster","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2019.02.002","article-title":"Studying interactions between dendritic cells and T-cells in vivo","volume":"58","author":"Chudnovsky","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xiao, Q., and Xia, Y. (2023). Insights into dendritic cell maturation during infection with application of advanced imaging techniques. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1140765"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5483\/BMBRep.2021.54.1.224","article-title":"The role of dendritic cells in tumor microenvironment and their uses in as therapeutic targets","volume":"54","author":"Kim","year":"2011","journal-title":"BMB Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"112725","DOI":"10.1016\/j.biopha.2022.112725","article-title":"The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study","volume":"148","author":"Derakhshani","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e15694","DOI":"10.1016\/j.heliyon.2023.e15694","article-title":"Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer","volume":"9","author":"Feriz","year":"2023","journal-title":"Heliyon"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/21655979.2020.1771068","article-title":"Dendritic cells in tumor microenvironment promoted the neuropathic pain via paracrine inflammatory and growth factors","volume":"11","author":"Wang","year":"2020","journal-title":"Bioengineered"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-\u03b1 in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jtho.2016.04.026","article-title":"Effect of first-line treatment on myeloid-derived suppressor cell subpopulations in the peripheral blood of patients with non-small cell lung cancer","volume":"11","author":"Koinis","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"15424","DOI":"10.1038\/s41598-017-14970-0","article-title":"Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration","volume":"7","author":"Markowitz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bruno, A., Mortara, L., Baci, D., Noonan, D.M., and Albini, A. (2019). Myeloid derived suppressor cells interactions with Natural Killer Cells and pro-angiogenic activities: Roles in tumor progression. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00771"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Siret, C., Collignon, A., Silvy, F., Robert, S., Cheyrol, T., Andre, P., Rigot, V., Iovanna, J., van der Pavert, S., and Lombardo, D. (2020). Deciphering crosstalk between myeloid-derived suppressor cells and regulatory T cells in pancreatic ductal adenocarcinoma. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03070"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Zhuang, J., Zhang, J., Lwin, S.T., Edwards, J.R., Edwards, C., Mundy, G.R., and Yang, X. (2012). Osteoclasts in multiple myeloma are derived from Gr1+ CD11b+ myeloid derived suppressor cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048871"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/MCB.00090-14","article-title":"Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression","volume":"34","author":"Garcia","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cjp2.160","article-title":"Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastasis of prostate cancer","volume":"6","author":"Wen","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00262-014-1591-2","article-title":"Correlation between frequencies of blood monocytic myeloid- derived suppressor cells, regulatory T cells and negative prognostic markers in patients with metastatic castration-resistant prostate cancer","volume":"63","author":"Idorn","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"vi257","DOI":"10.1093\/annonc\/mdw372.41","article-title":"Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS)","volume":"27","author":"Mehra","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Liu, A., Song, P., Liu, Z., Colucci, M., Lai, P., Yang, L., Yan, X., Qiu, H., and Dong, Q. (2026). Myeloid-derived suppresser cells promote therapy- induced resistance in prostate cancer. Int. J. Surg., online ahead of print.","DOI":"10.1097\/JS9.0000000000004227"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41391-022-00615-5","article-title":"Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: Systemic review and meta-analysis","volume":"26","author":"Bronte","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1158\/0008-5472.CAN-24-3748","article-title":"Prostate cancer cells secrete PD-1 in exosomes to enhance myeloid-derived suppressor cell activity and promote tumor immune evasion","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.trecan.2025.06.010","article-title":"MtDNA transfer from senescent cancer cells to MDSCs promotes immunosuppression","volume":"11","author":"Canadas","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kobayashi, T., Nagata, M., Hachiya, T., Wakita, H., Ikehata, Y., Takahashi, K., China, T., Shimizu, F., Lu, J., and Jin, Y. (2024). Increased circulating polymorphonuclear myeloid suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1372771"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Koinis, F., Xagara, A., Chantzara, E., Leontopoulou, V., Aidarinis, C., and Kotsakis, A. (2023). Myeloid-derived suppressor cells in prostate cancer: Present knowledge and future perspectives. Cells, 11.","DOI":"10.3390\/cells11010020"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid- derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Sormendi, S., and Wielock, B. (2018). Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment. Front. Oncol., 9.","DOI":"10.3389\/fimmu.2018.00040"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/HP.S53576","article-title":"PHD2, From hypoxic regulation to disease progression","volume":"53","author":"Wielockx","year":"2016","journal-title":"Hypoxia"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1152\/ajpcell.00204.2015","article-title":"Hypoxia-inducible factors in T lymphocyte differentiation and function. A review in the theme: Cellular responses to hypoxia","volume":"309","author":"Tao","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Chen, J.L.Y., Lucas, J.E., Shroeder, T., Mori, S., Wu, J., Nevins, J., Dewhurst, M., West, M., and Chi, J.T. (2008). The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet., 4.","DOI":"10.1371\/journal.pgen.1000293"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia Down regulates the expression of activating receptors involved in NK-cell mediated target cell killing without affecting, ADCC","volume":"123","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis un tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e20210564","DOI":"10.1084\/jem.20210564","article-title":"Lipid- loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer","volume":"219","author":"Masetti","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","article-title":"The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase family","volume":"87","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1107\/S2052252519013848","article-title":"Structure-based mechanism of cysteine-switch latency and of catalysis by pappalysin-family metallopeptidases","volume":"7","author":"Guevara","year":"2020","journal-title":"IUCrJ"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.31557\/APJCP.2022.23.7.2497","article-title":"Increasing immune dysfunction is associated with increasing matrix metalloproteinase expression and predicts men with bone marrow micrometastasis positive localized prostate cancer","volume":"23","author":"Murray","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/oncologie-2023-0368","article-title":"The role of matrix metalloproteinase 2 in the metastatic cascade: A review","volume":"26","author":"Murray","year":"2024","journal-title":"Oncologie"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","article-title":"Epigenetic regulation of T cell exhaustion","volume":"23","author":"Belk","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","article-title":"CD8+ T cell exhaustion and cancer immunotherapy","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Zhang, B., Liu, J., Mo, Y., Zhang, K., Huang, B., and Shang, D. (2024). CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: Key to the success of immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1476904"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor -reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","article-title":"Breast cancer cell-derived extracellular Vesicles promote CD8+ T cell exhaustion via TFG-beta type II receptor signaling","volume":"13","author":"Xie","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10 (+) and IL-35 (+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-gamma-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e12571","DOI":"10.1111\/cpr.12571","article-title":"PD-1\/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumors via the PI3K\/Akt\/mTOR signaling pathway","volume":"52","author":"Zhoa","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1368823","DOI":"10.1080\/20013078.2017.1368823","article-title":"Dominant immunosuppression of dendritic cell function by prostate cancer derived exosomes","volume":"6","author":"Salimu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1158\/0008-5472.CAN-06-1819","article-title":"Human tumor Released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes","volume":"66","author":"Valenti","year":"2006","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2020.06.006","article-title":"Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1\/Cdk2 signaling","volume":"225","author":"Lee","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13577-025-01257-0","article-title":"Blocking secretion of exosomes by GW4869 dampens CD8+ T cell exhaustion and prostate cancer progression","volume":"38","author":"Liu","year":"2025","journal-title":"Hum. Cell"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Krylova, S.V., and Feng, D. (2023). The machinery of exosomes: Biogenesis, release and uptake. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021337"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ciardiello, C., Cavallini, L., Spinelli, C., Yang, J., Reis-Sobreiro, M., de Candia, P., Minciacchi, M., and Di Vizio, D. (2016). Focus on extracellular vesicles: New frontiers of cell-to-cell communication in cancer. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020175"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Martellucci, S., Orefice, N.S., Angelucci, A., Luce, A., Caraglia, M., and Zappavigna, S. (2020). Extracellular vesicles: New endogenous shuttles for miRNAs in cancer diagnosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186486"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Wang, Y., Xiao, T., Zhao, C., and Li, G. (2024). The regulation and exosome generation and function in physiological and pathological Processes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010255"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2023.05.003","article-title":"Tumor-derived nanoparticles condition the soil for metastatic organotropism","volume":"93","author":"Hu","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/onc.2014.116","article-title":"Talin1 phosphorylation activates \u03b21 integrins: A novel mechanism to promote prostate cancer bone metastasis","volume":"34","author":"Jin","year":"2015","journal-title":"Oncogene"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e14550","DOI":"10.1111\/and.14550","article-title":"Role and correlation of exosomes and integrins in bone metastasis of prostate cancer","volume":"54","author":"Geng","year":"2022","journal-title":"Andrologia"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1038\/s41467-021-23946-8","article-title":"Tumor Microenvironment cytokines bound to cancer exosomes determines uptake by cytokine expressing cells and biodistribution","volume":"12","author":"Lima","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-L1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1158\/0008-5472.CAN-10-1722","article-title":"Cancer exosomes trigger fibroblast to myofibroblast Differentiation","volume":"70","author":"Webber","year":"2010","journal-title":"Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e12125","DOI":"10.1002\/jev2.12125","article-title":"Extracellular vesicles in the development of organ specific metastasis","volume":"10","author":"Urabe","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-319-23730-5_7","article-title":"MicroRNAs and prostate cancer","volume":"889","author":"Jossen","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"702","DOI":"10.17305\/bb.2025.12971","article-title":"Circulating microRNAs in prostate cancer-non-invasive biomarkers for diagnosis, prognosis and therapy: A review","volume":"26","author":"Volar","year":"2025","journal-title":"Biomol. Biomed."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Prigol, A.N., Rode, M.P., da Luz Efe, F., Saleh, N.A., and Creczynski-Pasa, C. (2023). The bone marrow microenvironment soil in prostate cancer metastasis: A miRNA approach. Cancers, 15.","DOI":"10.3390\/cancers15164027"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mc.23157","article-title":"Exosomes secreted by prostrate cancer cells under hypoxia promote metalloproteinase activity at pre-metastatic niches","volume":"59","author":"Deep","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ya, G., Ren, W., Qin, R., He, J., and Zhoa, S. (2002). Role of myeloid suppressor cells in the formation of the pre-metastatic niche. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.975261"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumour and tumour associated macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12672-025-02374-w","article-title":"Advances in the roles of and molecular mechanisms of exosomal circular RNAs in regulating the pre-metastatic niche of tumors","volume":"16","author":"Xu","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"432","DOI":"10.15407\/exp-oncology.2023.04.432","article-title":"Tumor microenvironment associated miR7-5p, miR-19a-3p and miRNA 23b-3p expression in prostate cancer the different progression risk","volume":"45","author":"Borikun","year":"2024","journal-title":"Exp. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/carcin\/bgz191","article-title":"Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Caherin and Epcam","volume":"41","author":"Voss","year":"2020","journal-title":"Carinogenesis"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1566339","DOI":"10.1016\/j.prp.2025.156339","article-title":"Extracellular vesicles in tumor environment modulate and clinical diagnosis","volume":"278","author":"Liu","year":"2026","journal-title":"Pathol. Res. Pract."},{"key":"ref_152","first-page":"473","article-title":"Premetastatic niche triggers SDF1\/CXC4R axis and organizes organ colonization by hepatocellular circulating tumour cells via downregulation of Prrx1","volume":"38","author":"Tang","year":"2019","journal-title":"J. Exp. Clin. Res."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Bach, C.A., Hossain, M.N., Chaudhari, I.J., Verrillo, C.E., Naranjo, N.M., Amoroso, I., Testa, A., Sey, S., Kelly, W.K., and Bellis, S.L. (2025). A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0329014"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid derived suppressor cells as regulators of the Immune System","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey stready state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.1103505","article-title":"MicroRNA 494 is required for the accumulation and functions of tumor expanded myeloid-derived suppressor cells via targeting of, PTEN","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.34388","article-title":"Urinary exosomal prostate specific antigen is a non-invasive biomarker to detect prostate cancer: Not only old wine in new bottles","volume":"152","author":"Wei","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100106","DOI":"10.1016\/j.jlb.2024.100162","article-title":"Decoding the mysteries of prostate cancer via cutting-edge liquid biopsy-based urine exosomes profiling","volume":"6","author":"Sonar","year":"2024","journal-title":"J. Liq. Biopsy"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Yap, X.I., Wood, B., Ong, T.A., Lim, J., Goh, B.H., and Lee, W.L. (2021). Detection of prostate cancer via IR spectroscopic analysis of urinary extracellular vesicles: A pilot study. Membranes, 11.","DOI":"10.3390\/membranes11080591"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.jlb.2023.100129","article-title":"Exosomes barcoding: A smart approach for cancer liquid biopsy","volume":"2","author":"Dhar","year":"2023","journal-title":"J. Liq. Biopsy"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"100138","DOI":"10.1016\/j.jlb.2024.100138","article-title":"Clinical impact of multi-omnics profiling of extracellular vesicles in cancer liquid biopsy","volume":"3","author":"Kulkarni","year":"2024","journal-title":"J. Liq. Biopsy"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Li, J., Zhang, L., Liu, R., Wu, C., Tang, H., Zou, Y., Cao, Q., and Huang, W. (2025). CXCL12\/CXCR$ axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: A dual therapeutic target in prostate cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1626708"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","article-title":"IL-2 driven CD8+ T cell phenotypes: Implications for immunotherapy","volume":"44","author":"Niederlova","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e180080","DOI":"10.1172\/JCI180080","article-title":"Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy","volume":"134","author":"Zhou","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-026-02617-6","article-title":"Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune environment remodeling in prostate cancer progression","volume":"25","author":"Yu","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_168","first-page":"5584406","article-title":"Exosomes derived from RM-1 cells promote the recruitment of MDSCs Into Tumor microenvironment by upregulating CXCR4 via TLR2\/NF-\u03baB pathway","volume":"8","author":"Li","year":"2021","journal-title":"J. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"Cxcl12-cxcr4\/cxcr7 axis in cancer: From mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"153110","DOI":"10.1016\/j.bbrc.2025.153110","article-title":"A comparative analysis of CXCR4 gene expression from published data bases and cell surface protein levels in breast and prostate cancer models","volume":"795","author":"Aydin","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbcan.2006.06.004","article-title":"TGF-\u03b2 as tumor suppressor and pro-metastatic factor in human cancer","volume":"1775","author":"Pardaili","year":"2007","journal-title":"Biochim. Biophs Acta Rev. Cancer"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"a021873","DOI":"10.1101\/cshperspect.a021873","article-title":"TNF-\u03b2 and the TNF-\u03b2 family: Context-dependent roles in cell and tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin 10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtstov","year":"2008","journal-title":"Immunity"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of tgf-\u03b2 signaling in treg and th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1152\/ajprenal.00260.2018","article-title":"Macrophage-secreted TGF-\u03b2 (1) contributes to fibroblast activation and urethral stricture after ablation injury","volume":"317","author":"Ueshima","year":"2019","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1073\/pnas.1615065114","article-title":"TGF-\u03b2 inhibits SMAD7 regulates dendritic cell-induced auto-immunity","volume":"114","author":"Lukas","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"34594","DOI":"10.1038\/srep34594","article-title":"B-cell derived transforming growth factor \u03b21 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjamadottir","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"a021907","DOI":"10.1101\/cshperspect.a021907","article-title":"Regulation of the bioavailability of TGF-beta and TGF-beta related proteins","volume":"8","author":"Robertson","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependant development program in mature regulatory T cells requires continued expression of Foxp3","volume":"8","author":"Williams","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02906127","article-title":"Micrometastatic bone marrow involvement: Detection and prognostic significance","volume":"16","author":"Braun","year":"1999","journal-title":"Med. Oncol."},{"key":"ref_182","first-page":"2107","article-title":"Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18\/PSA immunocytochemistry and PSA RT-PCR","volume":"20","author":"Albers","year":"2000","journal-title":"Anticancer Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002400050125","article-title":"Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy","volume":"27","author":"Weckermann","year":"1999","journal-title":"Urol. Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.1998.16.2.557","article-title":"Meta-analysis if studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated","volume":"16","author":"Funke","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2141.1998.01027.x","article-title":"Evaluation of breast cancer tumour cell contamination in the bone marrow and leukopheresis collections by RT-PCR for cytokeratin-19 mRNA","volume":"103","author":"Vannucchi","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.juro.2018.01.033","article-title":"Prostate cancer disseminated tumors cells are rarely detected in bone marrow of patients with localized disease undergoing radical prostatectomy across multiple rare cell detection platforms","volume":"199","author":"Chalfin","year":"2018","journal-title":"J. Urol."},{"key":"ref_187","first-page":"229","article-title":"Minimal residual disease in patients post radical prostatectomy for prostate cancer: Theoretical considerations, clinical implications and treatment","volume":"19","author":"Murray","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0032472031000141283","article-title":"Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells","volume":"5","author":"Borgen","year":"1999","journal-title":"Cytotherapy"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/ijlh.12365","article-title":"ICSH guidelines for the standardization of bone marrow immunohistochemistry","volume":"37","author":"Torlakovic","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1533038221100355","DOI":"10.1177\/15330338221100355","article-title":"Emerging Technologies for the Detection of Cancer micrometastasis","volume":"21","author":"Mao","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","article-title":"NCCN clinical practice guidelines in oncology: Prostate cancer version 3","volume":"23","author":"Spratt","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-24-0060","article-title":"Androgen deprivation therapy drives a distinct immune phenotype in localized prostate cancer","volume":"30","author":"Dallos","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"216468","DOI":"10.1016\/j.canlet.2023.216468","article-title":"Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of the T\u03b2RI expression","volume":"579","author":"Alsamraae","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/1078-0432.CCR-19-3372","article-title":"T-cell infiltration and adaptive Treg resistance in response to androgen deprivation with or without vaccination in localized prostate cancer","volume":"26","author":"Obradovic","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"333ra47","DOI":"10.1126\/scitranslmed.aad5659","article-title":"Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse","volume":"8","author":"Pu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockage efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","article-title":"AntiPD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer","volume":"41","author":"Hawley","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/2159-8290.CD-24-0559","article-title":"Androgen receptor inhibition increases MHC Class expression and improves immune response in prostate cancer","volume":"15","author":"Chesner","year":"2025","journal-title":"Cancer Discov."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Ganesan, R., Bhasin, S.S., Bokhtiary, M., Krishnan, U., Cheemarla, N.R., Thomas, B.E., Bhasin, M.K., and Sukhatme, V.P. (2023). Taxane chemo therapy induces stromal injury that leads to breast cancer dormancy escape. PLoS Biol., 21.","DOI":"10.1371\/journal.pbio.3002275"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"110214","DOI":"10.1016\/j.intimp.2023.110214","article-title":"The interactions of docetaxel with tumor microenvironment","volume":"119","author":"Gupta","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ccell.2023.05.009","article-title":"Taxanes trigger cancer cell killing in vivo inducing non-canonical T cell cytotoxicity","volume":"41","author":"Vennin","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13046-025-03614-1","article-title":"Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells","volume":"45","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1021\/acs.molpharmaceut.4c00514","article-title":"The chemo-immunotherapeutic roles of tumor-derived extracellular vesicle-based paclitaxel delivery system in hepatocarcinoma","volume":"21","author":"Bi","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12967-024-05347-9","article-title":"Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: From cancer therapy to regenerative medicine approaches","volume":"22","author":"Beheshtizadeh","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/acs.molpharmaceut.4c01440","article-title":"Docetaxel-loaded electrospun nanofibrous mats for local chemotherapy targeting positive surgical margins in prostate cancer","volume":"22","author":"Li","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"dju268","DOI":"10.1093\/jnci\/dju268","article-title":"Activated Lymphocyte recruitment into the tumor microenvironment following preoperative Sipuleucel-T for localized prostate cancer","volume":"106","author":"Fong","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-20-4476","article-title":"Randomized Phase II trial of sipuleucel T with or without radium-223 in men with bone metastatic castration resistant prostate cancer","volume":"27","author":"Marshall","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2426755","DOI":"10.1080\/07853890.2024.2426755","article-title":"Biomarkers in metastatic castration resistant prostate cancer for efficiency of immune checkpoint inhibitors","volume":"57","author":"Wu","year":"2015","journal-title":"Ann. Med."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Murray, N.P. (2025). Immunomodulation and Immunotherapy for patients with prostate cancer: An up-to-date review. Biomedicines, 13.","DOI":"10.20944\/preprints202503.0429.v1"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CJI.0000000000000364","article-title":"Immune checkpoint inhibitor-related Guillain-Barre Syndrome: A case series and review of the literature","volume":"44","author":"Janssen","year":"2021","journal-title":"J. Immunother."},{"key":"ref_214","first-page":"e51015","article-title":"Immunotherapy-induced hypophysitis following treatment with Tislelizimab in an elderly patient with bladder cancer and prostate cancer: A case report","volume":"15","author":"Zhang","year":"2023","journal-title":"Cureus"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40425-018-0473-0","article-title":"Myocarditis in a patient treated with nivolumab and PROSTVAC: A case report","volume":"6","author":"Monge","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Tay, S.H., Toh, M.M.X., Thian, Y.L., Vellayappan, B.A., Fairhurst, A.M., Chan, Y.H., Aminkeng, F., Bharwani, L.D., Huang, Y., and Mak, A. (2022). Cytokine release syndrome in cancer patients receiving immune checkpoint inhibitors: A case series of 25 patients and review of the literature. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.807050"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2372875","DOI":"10.1080\/2162402X.2024.2372875","article-title":"Cytokine release syndrome after treatment with immune checkpoint inhibitors: An observational cohort study of 2672 patients from Karolinska University Hospital in Sweden","volume":"13","author":"Hamida","year":"2024","journal-title":"Oncoimmunology"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with checkpoint inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis","volume":"64","author":"Kumar","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"119132","DOI":"10.1016\/j.lfs.2021.119132","article-title":"The role of regulatory T cells in the pathogenesis and treatment of prostate cancer","volume":"284","author":"Karpisheh","year":"2021","journal-title":"Life Sci."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"102255","DOI":"10.1016\/j.tranon.2024.102255","article-title":"Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy","volume":"52","author":"Ding","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Lupsa, N., Heninger, E., Ding, A.B., De Diego, C.S., Vietor, K., Reese, S.R., LeBeau, A.M., Kosoff, D., Beebe, D.J., and Kerr, S.C. (2026). Prostate cancer-associated fibroblasts: A review on CAF functions, heterogeneity, resistance mechanisms, and the future in a chip. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031585"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-024-03251-0","article-title":"Cancer-associated fibroblasts, tumor and radiotherapy: Interactions in the tumor microenvironment","volume":"43","author":"Raaijmakers","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Qiu, Y., Wang, Y., Liu, J., Sun, K., Liu, B., and Hou, Q. (2025). Single-cell sequencing unveils the transcriptomic landscape of castration- resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14212-x"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e010555","DOI":"10.1136\/jitc-2024-010555","article-title":"Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts","volume":"13","author":"Zhao","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1158\/2767-9764.CRC-24-0248","article-title":"Mechanistic characterization of cancer-associated fibroblast depletion via an antibody-drug conjugate targeting fibroblast activation protein","volume":"4","author":"Gallant","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"e187151","DOI":"10.1172\/jci.insight.187151","article-title":"Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer","volume":"10","author":"Hesterberg","year":"2025","journal-title":"JCI Insight"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12943-025-02436-1","article-title":"Targeting CXCR2 in prostate cancer cells can block CD47- SIRP\u03b1 interaction and reverse M2 macrophage polarization in the, TME","volume":"24","author":"Sun","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_228","first-page":"2156","article-title":"Re-education of Tumor-associated macrophages by CXCR2 blockage drives senescence and tumor inhibition in advanced prostate cancer","volume":"20","author":"Mirenda","year":"2019","journal-title":"Cell Rep."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/2326-6066.CIR-20-0312","article-title":"Targeted deletion of CXCR2 in myeloid cells alters the tumor microenvironment to improve antitumor immunity","volume":"9","author":"Yang","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1158\/0008-5472.CAN-07-1286","article-title":"Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo","volume":"67","author":"Loberg","year":"2007","journal-title":"Cancer Res."},{"key":"ref_231","first-page":"66157","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signaling as therapeutic strategy against hepatocellular carcinoma","volume":"67","author":"Li","year":"2017","journal-title":"Gut"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 8880) a human monoclonal antibody against CC-chemokine ligand 2 (CCL2) in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Investig. New Drugs"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"e004076","DOI":"10.1136\/jitc-2021-004076","article-title":"Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients na\u00efve or experienced for immune checkpoint inhibition","volume":"10","author":"Cassier","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/pros.23885","article-title":"The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors","volume":"79","author":"Hellsten","year":"2019","journal-title":"Prostate"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-21-0299","article-title":"Single-cell analysis reveals EP4 as a target for restoring T-cell infiltration and sensitizing prostate cancer to immunotherapy","volume":"28","author":"Peng","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Chen, Z., Yang, X., Chen, Z., Li, M., Wang, W., Yang, R., Wang, Z., Ma, Y., Xu, Y., and Ao, S. (2023). A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy. BMC Med., 21.","DOI":"10.1186\/s12916-023-03094-0"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleasing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"109309","DOI":"10.1016\/j.celrep.2021.109309","article-title":"Integrin \u03b1v\u03b28 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy","volume":"36","author":"Ma","year":"2021","journal-title":"Cell Rep."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"e006262","DOI":"10.1136\/jitc-2022-006262","article-title":"Immune and pathological responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib(CSF-1R inhibitor)","volume":"11","author":"Siddiqui","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Wang, H.C., Xia, R., Chang, W.H., Hsu, S.W., Wu, C.T., Chen, C.H., and Shih, T.C. (2024). Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1372956"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bju.16496","article-title":"Irreversible electroporation of localized prostate cancer downregulates immune suppression and induces anti-tumour-T-cell activation=IRE-IMMUNO study","volume":"135","author":"Geboers","year":"2025","journal-title":"BJU Int."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<521::AID-IJC4>3.0.CO;2-W","article-title":"Immunocytochemical monitoring of micro-metastatic disease reduction of bone marrow prostate cells in bone marrow by androgen deprivation","volume":"71","author":"Pantel","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1200\/JCO.2007.15.0441","article-title":"Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone therapy","volume":"26","author":"Kollermann","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/0970-1591.82838","article-title":"Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockade but not diethylstilbestrol","volume":"27","author":"Murray","year":"2011","journal-title":"Indian J. Urol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/CBM-150461","article-title":"PCA3 and PSA gene activity with the true tumor burden in prostate cancer lymph node metastases","volume":"15","author":"Tsaur","year":"2025","journal-title":"Cancer Biomark."},{"key":"ref_248","first-page":"71","article-title":"Genome-wide CRISPR-Cas9 screening and identification of potential genes promoting prostate cancer growth and metastasis","volume":"23","author":"Wang","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"102580","DOI":"10.1016\/j.eclinm.2024.102580","article-title":"An artificial intelligence model for detecting pathological lymph node metastasis in prostate cancer using whole slide images: A retrospective, multicentre diagnostic study","volume":"71","author":"Wu","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00345-024-05414-2","article-title":"More Micro-metastasis, more recurrence? The role of qPCR of PSA mRNA in lymph nodes during prostatectomy","volume":"43","author":"Troidl","year":"2025","journal-title":"World J. Urol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7256\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:07:13Z","timestamp":1786698433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":250,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167256"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167256","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}